Integral Health Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Integral Health Asset Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12M	Sell	45,000 -70,000	-61%	-$16.4M	0.47%	56
2026 Q1	$26.3M	Buy	115,000 +25,000	+28%	+$5.6M	1.26%	20
2025 Q4	$19.2M	Buy	90,000 +30,000	+50%	+$6.2M	0.95%	37
2025 Q3	$11.9M	Buy	+60,000	New	+$11.2M	0.81%	39
2025 Q2	–	Sell	-100,000	Closed	-$15.6M	–	75
2025 Q1	$15.6M	Buy	+100,000	New	+$14.3M	1.66%	15

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Integral Health Asset Management's ASND Position: Q2 2026 in Review

Integral Health Asset Management reduced its Ascendis Pharma A/S (ASND) stake by 61% in Q2 2026, selling an estimated $16.4M and leaving 45,000 shares worth $12M. The position accounts for 0.47% of the portfolio, ranked #56.

Integral Health Asset Management first reported a position in ASND in Q1 2025 and has held it in 5 quarters since. The position peaked at $26.3M in Q1 2026. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Integral Health Asset Management held 45,000 shares of Ascendis Pharma A/S worth $12M as of Q2 2026.
Integral Health Asset Management sold 70,000 Ascendis Pharma A/S shares in Q2 2026, an estimated $16.4M.
Ascendis Pharma A/S made up 0.47% of Integral Health Asset Management's portfolio in Q2 2026, its #56 holding.
Integral Health Asset Management first reported a position in Ascendis Pharma A/S in Q1 2025 and has held it in 5 quarters since.
Integral Health Asset Management's Ascendis Pharma A/S position peaked at $26.3M in Q1 2026.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.